Skip to main content
Pharmicell Co.,Ltd. logo

Pharmicell Co.,Ltd. — Investor Relations & Filings

Ticker · 005690 ISIN · KR7005690003 KO Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2024-07-16 Regulatory Filings
Country KR South Korea
Listing KO 005690

About Pharmicell Co.,Ltd.

https://www.pharmicell.com/eng/

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology and advanced bio-based materials. The company is a pioneer in regenerative medicine, having developed Hearticellgram-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its core business includes the development of stem cell therapeutics, a stem cell banking service for adult and cord blood cells, and a line of cosmetics based on stem cell culture media. A significant division focuses on fine chemicals, manufacturing and supplying critical raw materials for the pharmaceutical industry, such as nucleosides, mPEGs, and oligonucleotides for gene therapies. The company also produces eco-friendly flame retardants for industrial use.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Pharmicell regarding a 'Single Sale/Supply Contract' amendment. It details a change in the contract end date for a supply agreement with Thermo Fisher Scientific. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2024-07-16 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Pharmicell regarding a 'Single Sale/Supply Contract' amendment. It details a change in the contract end date for a supply agreement with Thermo Fisher Scientific. Since this is a specific disclosure of a commercial contract amendment filed with a regulatory body (DART in Korea), and it does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2024-07-16 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Pharmicell regarding a 'Single Sale/Supply Contract' amendment. It details a change in the contract period for a supply agreement with Thermo Fisher Scientific. Since this is a specific regulatory disclosure regarding a commercial contract update (a material event), and it does not fit into the specific categories like M&A or financial reports, it falls under the general regulatory filing category.
2024-07-15 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and a subsequent amendment (정정신고) to that contract. It details the contract terms, the counterparty (Thermo Fisher Scientific), and the reason for the amendment (contract period change). Since this is a specific regulatory disclosure of a material contract event that does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2024-07-15 Korean
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a court decision ('소송등의판결ㆍ결정') concerning a legal dispute (evidence preservation request) involving Pharmicell. It details the court's order, the case number, and the specific documents to be submitted. This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2024-07-01 Korean
기타시장안내 (업종변경)
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding a change in the company's industry classification code (SIC code) due to regulatory updates. It does not fit into specific categories like financial reports, dividends, or M&A. As it is a general regulatory notice issued by the exchange/company, it falls under the fallback category of Regulatory Filings (RNS).
2024-06-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.